These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32117427)

  • 21. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture.
    Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B
    Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction.
    Zheng P; Long Z; Gao A; Lu J; Wang S; Zhong C; Lai H; Guo Y; Wang K; Fang C; Mao X
    Front Genet; 2022; 13():1110799. PubMed ID: 36704346
    [No Abstract]   [Full Text] [Related]  

  • 23. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
    Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of biochemical recurrence after laparoscopic radical prostatectomy.
    Bejrananda T; Pliensiri P
    BMC Urol; 2023 Nov; 23(1):183. PubMed ID: 37953250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting survival of men with recurrent prostate cancer after radical prostatectomy.
    Dell'Oglio P; Suardi N; Boorjian SA; Fossati N; Gandaglia G; Tian Z; Moschini M; Capitanio U; Karakiewicz PI; Montorsi F; Karnes RJ; Briganti A
    Eur J Cancer; 2016 Feb; 54():27-34. PubMed ID: 26707594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-1, a Potential Predictive Biomarker for Recurrence in Prostate Cancer After Radical Prostatectomy.
    Wei W; Leng J; Shao H; Wang W
    Am J Med Sci; 2017 Apr; 353(4):315-319. PubMed ID: 28317618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.
    Duca RB; Massillo C; Farré PL; Graña KD; Moro J; Gardner K; Lacunza E; De Siervi A
    Front Oncol; 2022; 12():997457. PubMed ID: 36387263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy.
    Cai Y; Lin J; Wang Z; Ma Y; Pan J; Liu Y; Zhao Z
    Front Oncol; 2022; 12():1009921. PubMed ID: 36324578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database.
    He Y; Zhang J; Chen Z; Sun K; Wu X; Wu J; Sheng L
    Front Surg; 2022; 9():923473. PubMed ID: 37255653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
    Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
    Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
    Zhao Y; Tao Z; Li L; Zheng J; Chen X
    BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the prognostic nutritional index for the prognosis of Chinese patients with high/extremely high-risk prostate cancer after radical prostatectomy.
    Yang F; Pan M; Nie J; Xiao F; Zhang Y
    World J Clin Cases; 2022 Sep; 10(25):8863-8871. PubMed ID: 36157668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.
    Shi R; Bao X; Weischenfeldt J; Schaefer C; Rogowski P; Schmidt-Hegemann NS; Unger K; Lauber K; Wang X; Buchner A; Stief C; Schlomm T; Belka C; Li M
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy.
    Zhang ZN; Luo C; Xu B; Song HF; Ma BL; Zhang Q
    Cancer Manag Res; 2018; 10():4671-4677. PubMed ID: 30410401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
    Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.
    Erho N; Crisan A; Vergara IA; Mitra AP; Ghadessi M; Buerki C; Bergstralh EJ; Kollmeyer T; Fink S; Haddad Z; Zimmermann B; Sierocinski T; Ballman KV; Triche TJ; Black PC; Karnes RJ; Klee G; Davicioni E; Jenkins RB
    PLoS One; 2013; 8(6):e66855. PubMed ID: 23826159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.